These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 3199680)

  • 21. The pharmacodynamics of single doses of prorenoate potasssium and spironolactone in fludrocortisone treated normal subjects.
    Ramsay LE; Shelton JR; Tidd MJ
    Br J Clin Pharmacol; 1976 Jun; 3(3):475-82. PubMed ID: 788750
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Renal resistance to atrial natriuretic factor as a cause of the escape failure phenomenon in patients with non-ascitic liver cirrhosis].
    Tesar V; Spicák J; Horký K; Zabka J; Widimský J; Jedlicka J; Marecek Z
    Cas Lek Cesk; 1994 Feb; 133(4):111-5. PubMed ID: 8137382
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Faecal dry weight and potassium are related to faecal sodium and plasma aldosterone in rats chronically fed on varying amounts of sodium or potassium chlorides.
    McCabe RD; Smith MJ; Dwyer TM
    Br J Nutr; 1994 Aug; 72(2):325-37. PubMed ID: 7947649
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Paradoxical potassium excretion in response to aldosterone antagonists.
    Ramsay LE; Harrison IR; Shelton JR; Tidd MJ
    Eur J Clin Pharmacol; 1977 Jan; 11(2):101-5. PubMed ID: 837961
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Urinary prostasin: a candidate marker of epithelial sodium channel activation in humans.
    Olivieri O; Castagna A; Guarini P; Chiecchi L; Sabaini G; Pizzolo F; Corrocher R; Righetti PG
    Hypertension; 2005 Oct; 46(4):683-8. PubMed ID: 16172430
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hyperaldosteronism after decreased renal K+ excretion in KCNMB2 knockout mice.
    Larsen CK; Jensen IS; Sorensen MV; de Bruijn PI; Bleich M; Praetorius HA; Leipziger J
    Am J Physiol Renal Physiol; 2016 May; 310(10):F1035-46. PubMed ID: 26962098
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Circadian Potassium Excretion is Unaffected Following Furosemide Induced Increase in Sodium Delivery to the Distal Nephron.
    Ilenwabor BP; Asowata EO; Obika LF
    Niger J Physiol Sci; 2017 Jun; 32(1):1-6. PubMed ID: 29134970
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mechanism of renal potassium conservation in the rat.
    Linas SL; Peterson LN; Anderson RJ; Aisenbrey GA; Simon FR; Berl T
    Kidney Int; 1979 Jun; 15(6):601-11. PubMed ID: 222934
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of administered mineralocorticoids or ACTH in pregnant women. Attenuation of kaliuretic influence of mineralocorticoids during pregnancy.
    Ehrlich EN; Lindheimer MD
    J Clin Invest; 1972 Jun; 51(6):1301-9. PubMed ID: 4336938
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of mineralocorticoids on Na+ and K+ excretion in the adrenalectomized rat.
    Horisberger JD; Diezi J
    Am J Physiol; 1983 Jul; 245(1):F89-99. PubMed ID: 6869541
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dose-response relationships for spironolactone in combination with a potassium-wasting diuretic.
    McInnes GT; Clarke JM; Shelton JR
    Clin Pharmacol Ther; 1983 Jan; 33(1):35-43. PubMed ID: 6848297
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of aldosterone on potassium excretion during potassium chloride infusion in sheep.
    Rabinowitz L; Sarason RL; Yamauchi H
    Am J Physiol; 1985 Oct; 249(4 Pt 2):R455-61. PubMed ID: 4051031
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of aldosterone antagonists in healthy man.
    McInnes GT; Shelton JR; Ramsay LE
    Methods Find Exp Clin Pharmacol; 1982; 4(1):49-71. PubMed ID: 7045549
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adrenocorticotropin and cortisol-induced changes in urinary sodium and potassium excretion in man: effects of spironolactone and RU486.
    Clore JN; Estep H; Ross-Clunis H; Watlington CO
    J Clin Endocrinol Metab; 1988 Oct; 67(4):824-31. PubMed ID: 2843562
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The influence of endogenous mineralocorticoids on the composition of fetal urine.
    Kairaitis K; Lumbers ER
    J Dev Physiol; 1990 Jun; 13(6):347-51. PubMed ID: 2084194
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Kaliuretic response to aldosterone: influence of the content of potassium in the diet.
    Vasuvattakul S; Quaggin SE; Scheich AM; Bayoumi A; Goguen JM; Cheema-Dhadli S; Halperin ML
    Am J Kidney Dis; 1993 Feb; 21(2):152-60. PubMed ID: 8430675
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impaired renal tubular potassium secretion in systemic lupus erythematosus.
    DeFronzo RA; Cooke CR; Goldberg M; Cox M; Myers AR; Agus ZS
    Ann Intern Med; 1977 Mar; 86(3):268-71. PubMed ID: 842984
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antagonism of endogenous mineralocorticoids in normal subjects by prorenoate potassium and spironolactone.
    Levine D; Ramsay L; Auty R; Branch R; Tidd M
    Eur J Clin Pharmacol; 1976 Mar; 09(5-6):381-6. PubMed ID: 786663
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Short-term indomethacin administration does not impair excretion of acute potassium load in humans.
    Van Buren M; Van Rijn HJ; Koomans HA
    Eur J Clin Invest; 1992 Dec; 22(12):821-6. PubMed ID: 1478254
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Improved method for comparative evaluation of aldosterone antagonists in healthy man.
    Casals-Stenzel J; Schmalbach J; Losert W
    Eur J Clin Pharmacol; 1977 Dec; 12(4):247-55. PubMed ID: 590311
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.